Supplementary Figure legends
B-C. The protein abundance of BRD4 in 40 pairs of fresh HNSCC samples and adjacent non-tumour epithelial was determined by western blot. Representative images of western blot were shown from 16 pairs of samples (B) . Quantification data of BRD4 protein were shown (C). Paired t test, *P < 0.05, **P < 0.01. Figure S4 . BRD4 knockdown enhances the chemotherapeutic sensitivity in HNSCC A-B. Cell viability was significantly impaired in BRD4-knockdown cells treated with 5-FU (2.5μg/ml) or cisplatin (2.5μg/ml) alone than those treated with vehicle. Student's t test, *P < 0.05, **P < 0.01. B. Cell proliferation was remarkably accelerated following BRD4 overexpression as assayed by MTT viability and colony formation. Student's t test, *P < 0.05, **P < 0.01.
C-D.
Cell migration and invasion abilities of HN6 with or without BRD4 overexpression were measured by wound healing and transwell invasion assays. Student's t test, *P < 0.05, **P < 0.01.
Cal27 and Fadu cells were clustered and shown in heatmap.
B. GSEA analyses revealed that genes regulated by JQ1 in Cal27 cells were significantly enriched in GO categories: regulation of cell proliferation and growth.
C. Several gene candidates downregulated by JQ1 were aberrantly overexpressed in cancer samples in TCGA-HNSCC dataset. This analysis was performed using online platform http://gepia.cancer-pku.cn/.
Student's t test, *P < 0.05, **P < 0.01.
D.
Among 52 top downregulated genes, expression status of 4 genes (median values as cutoff) were found to be significantly associated with overall survival in TCGA-HNSCC dataset (Log-rank test). Median value of BRD4 mRNA was used as cutoff to stratify patients into BRD4 low or high subgroups.
The number in bold indicate statistical significance with P-values less than 0.05. 
